Vicore Pharma Holding AB (publ) (STO: VICO)
Sweden
· Delayed Price · Currency is SEK
7.78
+0.01 (0.13%)
Nov 21, 2024, 5:29 PM CET
Vicore Pharma Holding AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 336.62 | 333.62 | 256.8 | 294.2 | 248.62 | 187.59 | Upgrade
|
Short-Term Investments | 43.8 | 149.15 | 4.94 | 77.28 | 70.12 | 77.03 | Upgrade
|
Cash & Short-Term Investments | 380.42 | 482.77 | 261.74 | 371.48 | 318.74 | 264.62 | Upgrade
|
Cash Growth | -31.02% | 84.44% | -29.54% | 16.55% | 20.45% | 17.77% | Upgrade
|
Other Receivables | 2.2 | 3.13 | 2.18 | 1.42 | 8.51 | 1.43 | Upgrade
|
Receivables | 2.2 | 3.13 | 2.18 | 1.42 | 8.51 | 1.43 | Upgrade
|
Prepaid Expenses | 24.28 | 9.7 | 5.87 | 5.03 | 0.61 | 0.47 | Upgrade
|
Total Current Assets | 406.9 | 495.6 | 269.79 | 377.93 | 327.85 | 266.52 | Upgrade
|
Property, Plant & Equipment | 0 | 0.03 | 0.12 | 0.4 | 0.25 | 0.33 | Upgrade
|
Long-Term Investments | - | - | - | 5.41 | 7.53 | 6.12 | Upgrade
|
Other Intangible Assets | - | 2.22 | 68.1 | 67.43 | 70.76 | 68.08 | Upgrade
|
Long-Term Deferred Tax Assets | - | - | - | - | 0.13 | 0.06 | Upgrade
|
Total Assets | 406.9 | 497.84 | 338.01 | 451.17 | 406.52 | 341.11 | Upgrade
|
Accounts Payable | 12.43 | 17.92 | 23.5 | 23.98 | 10.94 | 5.3 | Upgrade
|
Accrued Expenses | 12.53 | 14.65 | 18.22 | 40.14 | 29.53 | 8.02 | Upgrade
|
Current Portion of Leases | - | - | 0.07 | - | 0.14 | 0 | Upgrade
|
Current Income Taxes Payable | 0.84 | 1.13 | 0.76 | 0.34 | 0.55 | 0.53 | Upgrade
|
Other Current Liabilities | 2.71 | 7.27 | 3.88 | 1.26 | 6.92 | 3.09 | Upgrade
|
Total Current Liabilities | 28.52 | 40.96 | 46.42 | 65.72 | 48.09 | 16.95 | Upgrade
|
Long-Term Leases | - | - | - | 0.32 | - | 0.19 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.31 | 0.59 | 0.91 | 1.21 | 1.53 | 1.8 | Upgrade
|
Other Long-Term Liabilities | 0.34 | 0.9 | 1.6 | 0.6 | 2.39 | 0.58 | Upgrade
|
Total Liabilities | 29.17 | 42.45 | 48.92 | 67.85 | 52 | 19.51 | Upgrade
|
Common Stock | 55.87 | 55.86 | 40.92 | 35.88 | 30.21 | 25.09 | Upgrade
|
Additional Paid-In Capital | - | 1,674 | 1,211 | 1,022 | 702.05 | 527.4 | Upgrade
|
Retained Earnings | - | -1,274 | -962.65 | -674.23 | -377.75 | -230.89 | Upgrade
|
Comprehensive Income & Other | 321.87 | - | - | - | - | - | Upgrade
|
Shareholders' Equity | 377.74 | 455.39 | 289.08 | 383.32 | 354.51 | 321.6 | Upgrade
|
Total Liabilities & Equity | 406.9 | 497.84 | 338.01 | 451.17 | 406.52 | 341.11 | Upgrade
|
Total Debt | - | - | 0.07 | 0.32 | 0.14 | 0.19 | Upgrade
|
Net Cash (Debt) | 380.42 | 482.77 | 261.68 | 371.16 | 318.6 | 264.43 | Upgrade
|
Net Cash Growth | -31.02% | 84.49% | -29.50% | 16.50% | 20.49% | 17.69% | Upgrade
|
Net Cash Per Share | 3.40 | 5.00 | 3.62 | 5.33 | 5.87 | 6.14 | Upgrade
|
Filing Date Shares Outstanding | 111.73 | 111.72 | 81.85 | 71.76 | 71.76 | 50.42 | Upgrade
|
Total Common Shares Outstanding | 111.73 | 111.72 | 81.85 | 71.76 | 60.42 | 50.17 | Upgrade
|
Working Capital | 378.38 | 454.64 | 223.37 | 312.21 | 279.76 | 249.56 | Upgrade
|
Book Value Per Share | 3.38 | 4.08 | 3.53 | 5.34 | 5.87 | 6.41 | Upgrade
|
Tangible Book Value | 377.74 | 453.17 | 220.98 | 315.89 | 283.76 | 253.52 | Upgrade
|
Tangible Book Value Per Share | 3.38 | 4.06 | 2.70 | 4.40 | 4.70 | 5.05 | Upgrade
|
Machinery | - | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.